Letter: prognostic scoring systems for hepatocellular carcinoma patients – the jury is still out

E-ISSN： 1365-2036|41|6|596-597

ISSN： 0269-2813

Source： ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol.41, Iss.6, 2015-03, pp. : 596-597

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Addition of C-Reactive Protein to Validated Staging Systems Improves Their Prognostic Ability in Patients with Hepatocellular Carcinoma

Oncology, Vol. 86, Iss. 5-6, 2014-06 ,pp. : 308-317

Karger

Access to resources Recommend Favorite

Nicotinamide and skin cancer chemoprevention: The jury is still out

AUSTRALASIAN JOURNAL OF DERMATOLOGY, Vol. 59, Iss. 1, 2018-02 ,pp. : 6-9

John Wiley & Sons Inc

Access to resources Recommend Favorite

FIB‐4 as a prognostic model for patients with hepatitis B–associated hepatocellular carcinoma

HEPATOLOGY, Vol. 270-9139, Iss. 4, 2015-10 ,pp. : 1325-1326

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prognostic Factors in Patients with Hepatocellular Carcinoma Refractory or Intolerant to Sorafenib

Oncology, Vol. 88, Iss. 4, 2014-12 ,pp. : 241-246

Karger

Access to resources Recommend Favorite

FIB‐4 as a prognostic model for patients with hepatitis B–associated hepatocellular carcinoma

HEPATOLOGY, Vol. 62, Iss. 4, 2015-10 ,pp. : 1325-1326

John Wiley & Sons Inc

Access to resources Recommend Favorite